Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Chronic Heart Failure (CHF)Iron Deficiency
Interventions
DRUG

Iron Sucrose IV

"Intervention will consisted of the administration for the IV route.~-The IV route in two doses will be diluted bolus injection of iron or normal saline at day 0 and day 14."

DRUG

Ferric polymaltose hydroxide complex IM

Intervention will consisted of the administration for the IM route. Drug will be given in two series of injection; the first series will began at day 0 and consist of administration of 300 mg of iron per day in intramuscular injection up to the half of the total dose and the second series will began at day 14 for the administration of the other half with the same scheme than the first.

OTHER

Saline solution

100 ml i.v. of normal saline administered at Day 0 and at day 14.

Trial Locations (1)

Unknown

Yaounde Central Hospital, Cardiology department, Yaoundé

All Listed Sponsors
lead

CN NGANOU-GNINDJIO, MD, MSc

OTHER_GOV

NCT04225728 - Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study | Biotech Hunter | Biotech Hunter